neurotensin (8-13) has been researched along with quinpirole in 1 studies
| Studies (neurotensin (8-13)) | Trials (neurotensin (8-13)) | Recent Studies (post-2010) (neurotensin (8-13)) | Studies (quinpirole) | Trials (quinpirole) | Recent Studies (post-2010) (quinpirole) |
|---|---|---|---|---|---|
| 66 | 0 | 10 | 2,213 | 0 | 367 |
| Protein | Taxonomy | neurotensin (8-13) (IC50) | quinpirole (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kruse, CG; Long, SK; Nievelstein, H; Wadman, WJ; Werkman, TR | 1 |
1 other study(ies) available for neurotensin (8-13) and quinpirole
| Article | Year |
|---|---|
Neurotensin attenuates the quinpirole-induced inhibition of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area.
Topics: Action Potentials; Adamantane; Animals; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Electrophysiology; Imidazoles; In Vitro Techniques; Logistic Models; Male; Neurons; Neurotensin; Peptide Fragments; Quinpirole; Rats; Rats, Wistar; Receptors, Neurotensin; Substantia Nigra; Ventral Tegmental Area | 2000 |